Relmada Therapeutics, Inc.
RLMD
$0.6999
-$0.0041-0.58%
NASDAQ
03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | -39.74% | -17.02% | -23.17% | -15.76% | -13.20% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -32.72% | -44.06% | 194.85% | -28.55% | -36.52% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | -39.61% | -17.79% | -21.52% | -15.87% | -13.48% |
|
|||||
Total Current Assets | -39.61% | -17.79% | -21.52% | -15.87% | -13.48% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 0.00% | 0.00% | -58.96% | 24.36% | 0.00% |
Total Assets | -39.59% | -17.78% | -21.55% | -15.85% | -13.47% |
|
|||||
Total Accounts Payable | -69.37% | 76.11% | -43.81% | -19.55% | 48.01% |
Total Accrued Expenses | -35.62% | 7.31% | 7.07% | -25.24% | -17.45% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
Total Other Current Liabilities | -- | -- | -- | -- | -- |
Total Current Liabilities | -49.17% | 27.26% | -15.20% | -22.85% | 1.37% |
|
|||||
Total Current Liabilities | -49.17% | 27.26% | -15.20% | -22.85% | 1.37% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 66.67% | -64.29% | -- | -- | -- |
Total Liabilities | -49.12% | 27.12% | -15.07% | -22.85% | 1.37% |
|
|||||
Common Stock & APIC | 0.66% | 0.98% | 1.19% | 1.10% | 1.32% |
Retained Earnings | -2.74% | -3.00% | -3.62% | -3.05% | -3.89% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -36.83% | -25.41% | -22.55% | -14.65% | -15.59% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -36.83% | -25.41% | -22.55% | -14.65% | -15.59% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -36.83% | -25.41% | -22.55% | -14.65% | -15.59% |
|